A randomized crossover trial of elamipretide in adults with primary mitochondrial myopathy
Abstract Background This study aims to evaluate the effect of subcutaneous (SC) elamipretide dosing on exercise performance using the 6 min walk test (6MWT), patient‐reported outcomes measuring fatigue, functional assessments, and safety to guide the development of the Phase 3 trial. Methods MMPOWER...
Gespeichert in:
| Hauptverfasser: | , , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Wiley
2020-08-01
|
| Schriftenreihe: | Journal of Cachexia, Sarcopenia and Muscle |
| Schlagworte: | |
| Online-Zugang: | https://doi.org/10.1002/jcsm.12559 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|